Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.26M | 3.12M | 20.15M | -26.73M | -3.64M | Gross Profit |
19.15M | 2.15M | 19.22M | -27.62M | -4.55M | EBIT |
5.82M | 2.27M | 5.80M | -33.83M | -9.75M | EBITDA |
5.91M | 3.24M | 6.73M | -32.94M | -9.03M | Net Income Common Stockholders |
5.00M | 2.19M | 5.76M | -34.01M | -9.88M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
299.84M | 177.96M | 137.63M | 156.54M | 225.14M | Total Assets |
548.58M | 550.22M | 564.03M | 612.68M | 656.35M | Total Debt |
1.38M | 2.23M | 475.00K | 1.39M | 2.26M | Net Debt |
-212.21M | -38.34M | -6.18M | -11.99M | -14.55M | Total Liabilities |
5.87M | 2.55M | 770.00K | 1.68M | 2.60M | Stockholders Equity |
542.71M | 547.67M | 563.26M | 611.00M | 653.75M |
Cash Flow | Free Cash Flow | |||
178.84M | 28.56M | -15.37M | -19.35M | -1.77M | Operating Cash Flow |
178.84M | 28.62M | -14.95M | -19.35M | -1.77M | Investing Cash Flow |
-4.97M | 6.18M | 9.14M | 16.79M | 6.78M | Financing Cash Flow |
-854.00K | -883.00K | -915.00K | -871.00K | -894.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | HK$84.72B | 3.59 | 1.64% | 7.65% | -13.56% | -84.68% | |
64 Neutral | $12.93B | 9.70 | 7.85% | 78.03% | 12.07% | -7.83% | |
63 Neutral | HK$503.10M | 7.99 | 2.12% | ― | -4.66% | -77.08% | |
57 Neutral | HK$1.23B | 37.97 | 2.65% | 1.33% | -60.81% | -21.00% | |
51 Neutral | HK$128.02M | 25.00 | 0.92% | ― | 545.43% | 100.00% | |
44 Neutral | HK$64.87M | ― | -2.19% | ― | 5.28% | 86.91% | |
€1.16B | 17.22 | 4.34% | ― | ― | ― |
China Innovation Investment Limited announced its unaudited net asset value per share as of May 31, 2025, which stands at approximately HK$0.045. This announcement provides stakeholders with an insight into the company’s financial health and market positioning, potentially impacting investor confidence and future investment decisions.
China Innovation Investment Limited announced that all proposed resolutions at their 2024 Annual General Meeting were passed unanimously by shareholders. The resolutions included the re-election of independent non-executive directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of a general mandate to the directors. This unanimous approval reflects strong shareholder support and positions the company for continued stability and strategic decision-making.
China Innovation Investment Limited has announced a pre-conditional voluntary cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited, representing approximately 13.27% of its issued share capital. This move, subject to certain pre-conditions and conditions, aims to enhance the Offeror’s stake in Elife Holdings, potentially impacting the company’s market positioning and shareholder dynamics.
China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$0.046 as of April 30, 2025. This financial update provides stakeholders with a snapshot of the company’s financial health, potentially impacting investor perception and market positioning.
China Innovation Investment Limited has announced its upcoming Annual General Meeting (AGM) to be held on May 23, 2025, in Hong Kong. The meeting will address several key issues, including the review of the company’s financial statements, re-election of directors, and re-appointment of auditors. Additionally, resolutions will be considered regarding the repurchase of company shares and the issuance of additional shares, which could impact the company’s market operations and shareholder value.
China Innovation Investment Limited announced that its unaudited net asset value per share as of March 31, 2025, was approximately HK$0.045. This update provides stakeholders with insight into the company’s financial position, which is crucial for assessing its market value and investment potential.
China Innovation Investment Limited reported a significant increase in turnover for the year ending December 31, 2024, reaching approximately HK$687.9 million compared to HK$387.6 million in 2023. The company achieved a net profit attributable to equity shareholders of approximately HK$5 million, up from HK$2.2 million in the previous year, driven by net realized gains on investment disposals. Despite the profit increase, the company’s net assets slightly decreased due to adverse economic conditions affecting the fair value of equity investments.